ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Medicare Cuts Payments To Physicians By 21%. House Bill Would Mandate Medicare Coverage Of CT Scans For Colorectal Cancer Screening

June 4, 2010

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Charges Against CC Probed; Most Found Invalid

March 31, 1978